You have no items in your shopping cart.
TIOVA Rotacaps are indicated for the long-term, once-daily maintenance treatment of bronchospasm associated with COPD, including chronic bronchitis and emphysema.
The recommended dosage of TIOVA Rotacaps is one Rotacap inhaled once daily, using the Cipla Rotahaler/ Revolizer.
No dosage adjustment is required for geriatric, hepatically-impaired, or renally-impaired patients. However, patients with moderate to severe renal impairment, who are being treated with TIOVA Rotacaps should be monitored closely.
TIOVA Rotacaps are for inhalation only and must not be swallowed.
TIOVA Rotacaps are contraindicated in patients with a history of hypersensitivity to atropine or its derivatives, including ipratropium, or to any component of this product.